Click here to JOIN OUR MAILING LIST
CLL Ireland
  • HOME
  • ABOUT US
  • CONTACT US
  • DONATE
  • Search
  • Menu
  • Twitter
  • Facebook
  • Linkedin
  • Instagram
  • Living with CLL
    • What is Leukaemia?
    • What is CLL?
    • Symptoms & Diagnosis
    • Stories from the CLL Community
    • Healthcare Teams
    • Complications
    • Living Well
  • Treatment
    • Prognostic Markers
    • iwCLL Guidelines
    • Questions for your Doctor
    • Staging CLL
    • Managing Treatment
    • Chemotherapy
    • Biological Therapies
    • Clinical Trials
    • Supportive & other therapies
    • Stem Cell Transplants
  • Support
    • During Cancer Treatment
    • Caregivers
    • Telling children & teenagers
    • Legal support & advice
    • Benefits & Allowances
    • Financial support & advice
  • Community & Research
    • Community groups
    • International groups
    • CLL Statistics
    • Get involved
    • Sign up for emails
  • FAQs
    • A-Z Glossary of Terms
    • Consultants & Clinicians
    • Understanding Lab Tests
  • News & Events
    • Latest News
    • Upcoming Events
    • CLL Ireland Videos
    • CLL Presentations
    • CLL Ireland in the Media

Professor Patrick Thornton

Consultant Haematologist, Senior Lecturer RCSI, and Clinical Director Hermitage Medical Clinic Laboratory.

Professor Patrick Thornton discusses difficulties in getting access to Venetoclax for the treatment of Chronic Lymphocytic Leukaemia (CLL) in patients in Ireland.

This interview was recorded at the CLL Ireland Information Day 2018 held in Dublin, Ireland, on 5 May 2018.

Go To - CLL Ireland Videos

Followon TwitterSubscribeto RSS Feed
© Copyright - CLL Ireland 2020
  • Twitter
  • Facebook
  • Linkedin
  • Instagram
  • PRIVACY
  • EMAIL SIGN UP
  • POLICIES & DISCLAIMERS
  • CONTACT US
VM – patient Patients Shane Coleman interviews Prof Hillmen Professor Peter Hillmen
Scroll to top
This site uses cookies: Find out more.